Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: GlobalData
Provider: Reuters Investment Profile
Provider: Wright Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Oncolys Biopharma to receive subsidy from NEDO

Wednesday, 14 May 2014 04:00am EDT 

Oncolys Biopharma Inc:To receive subsidy up to 125,313,000 yen from New Energy and Industrial Technology Development Organization, for development of epigenetic drug for metastatic renal cell carcinoma patient, from May 14, 2014 to Feb. 28, 2015. 

Related Company News